Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
SIGLEC6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LOC643711 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
P2RY13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIR181A2HG - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MEGF10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CLDN11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IL17A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EID3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PEX5L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GGT6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HIST1H3C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC6A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TTC30B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRCP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KLRC4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on